• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,704.13 633.29
( 0.83%)
Global Indices
Nasdaq
47,030.54 63.12
(0.13%)
Dow Jones
6,739.22 18.84
(0.28%)
Hang Seng
55,100.12 1,399.73
(2.61%)
Nikkei 225
10,289.25 -114.35
(-1.10%)
Forex
USD-INR
92.33 0.01
(0.01%)
EUR-INR
105.92 0.52
(0.49%)
GBP-INR
122.63 0.58
(0.47%)
JPY-INR
0.58 0.00
(0.31%)

EQUITY - MARKET SCREENER

Medinova Diagnostic Services Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
526301
INE047C01019
-0.5896426
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
40.61
43.37
EPS(TTM)
Face Value()
Div & Yield %
1.07
10
0
 

Jindal Saw surges over 20% in two days on robust sequential Q3 performance
Jan 20,2026
Shares of Jindal Saw surged 20.28% in two trading sessions from its recent closing low of Rs 154.85 recorded on 16 January 2026.

Meanwhile, the company reported a 69.85% jump in consolidated net profit to Rs 257.99 crore on 16.77% increase in revenue from operations to Rs 4,943.41 crore in Q3 FY26 over Q2 FY26.

On a Year on year (YoY) basis, the company’s consolidated net profit and revenue from operations declined 49.06% and 6.22% respectively in Q3 FY26.

EBITDA stood at Rs 632.2 crore in Q3 FY26, up 31.27% QoQ while down 34.24% YoY. The EBITDA margin improved to 12.7% in Q3 FY26 from 11.3% in Q2 FY26, but moderated from 16.8% in Q3 FY25.

Jindal Saw is engaged into manufacturing of iron and steel pipes and pellets.